How big is the Global Orphan Drugs Market?

The Global Orphan Drugs Market size is expected to reach USD 217.35 billion in 2024 and grow at a CAGR of 6.24% to reach USD 294.17 billion by 2029. Read More

What is the current Global Orphan Drugs Market size?

In 2024, the Global Orphan Drugs Market size is expected to reach USD 217.35 billion. Read More

Who are the key players in Global Orphan Drugs Market?

Takeda Pharmaceutical Company Limited, Novartis AG, Johnson & Johnson, F. Hoffmann-La Roche Ltd and Bristol-Myers Squibb Company (Celgene Corporation) are the major companies operating in the Global Orphan Drugs Market. Read More

Which is the fastest growing region in Global Orphan Drugs Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Global Orphan Drugs Market?

In 2024, the North America accounts for the largest market share in Global Orphan Drugs Market. Read More

What years does this Global Orphan Drugs Market cover, and what was the market size in 2023?

In 2023, the Global Orphan Drugs Market size was estimated at USD 204.58 billion. The report covers the Global Orphan Drugs Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Global Orphan Drugs Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Global Orphan Drugs Market Share

Statistics for the 2023 & 2024 Global Orphan Drugs market share, created by Mordor Intelligence™ Industry Reports. Global Orphan Drugs share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Global Orphan Drugs Industry

The orphan drugs market is moderately competitive. In terms of market share, a few of the major players currently dominate the market. With the rising number of diseases and an increasing number of cases each year, a few smaller players are entering the market and holding a substantial share. Some of the market players include Celgene Corporation, Takeda Pharmaceutical Company Limited, Novartis AG, Johnson & Johnson, F. Hoffmann-La Roche Ltd and others.